Apidra and Ultram drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Apidra (insulin glulisine recombinant) and Ultram (tramadol hydrochloride). Common drug interactions include thyroid mass among females and foot deformity among males.

The phase IV clinical study analyzes what interactions people have when they take Apidra and Ultram. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Apidra?

Apidra has active ingredients of insulin glulisine recombinant. It is often used in diabetes. eHealthMe is studying from 10,548 Apidra users. Check the latest studies of Apidra.

What is Ultram?

Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

22 people who take Apidra and Ultram together, and have interactions are studied.

Apidra and Ultram drug interactions.

What are the common drug interactions of Apidra and Ultram, by gender? *:

female:

  1. Thyroid mass
  2. Tremor (trembling or shaking movements in one or more parts of your body)
  3. Weight increased
  4. Pancreatitis (inflammation of pancreas)
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Arthropathy
  7. Eye disorder
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  9. Papillary thyroid cancer
  10. Coronary artery stenosis (narrowing of coronary artery)

male:

  1. Foot deformity (functional disability of foot)
  2. Headache (pain in head)
  3. Cardiac disorder
  4. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  5. Cataract (clouding of the lens inside the eye)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Chest pain
  8. Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
  9. Cystitis interstitial (unknown cause characterized by bladder pain)
  10. Death

What are the common drug interactions of Apidra and Ultram, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Cough

50-59:

  1. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  2. Papillary thyroid cancer
  3. Anal abscess
  4. Basedow's disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones)
  5. Cardiac arrest
  6. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  7. Chronic kidney disease
  8. Dehydration (dryness resulting from the removal of water)
  9. Genital abscess (build up of pus in genital)
  10. Headache (pain in head)

60+:

  1. Arthropathy
  2. Eye disorder
  3. Behcet's syndrome (involves inflammation of the blood vessels)
  4. Blood glucose decreased
  5. Blood glucose increased
  6. Bradyarrhythmia (heart slowness)
  7. Cardiac disorder
  8. Cataract (clouding of the lens inside the eye)
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Chest pain

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 7 people, 31.82%
  2. Muscle Spasms (muscle contraction): 4 people, 18.18%
  3. High Blood Pressure: 4 people, 18.18%
  4. Wheezing (a high-pitched whistling sound made while you breath): 3 people, 13.64%
  5. Cough: 3 people, 13.64%
  6. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 13.64%
  7. Migraine (headache): 3 people, 13.64%
  8. High Blood Cholesterol: 2 people, 9.09%
  9. Depression: 2 people, 9.09%
  10. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Apidra and Ultram?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Apidra and Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Apidra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Apidra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ultram and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on insulin glulisine recombinant and tramadol hydrochloride (the active ingredients of Apidra and Ultram, respectively), and Apidra and Ultram (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: